PASVILDA
LIVE

Serial Number

79420232

Owner

SANDOZ AG

Filing Date

Jan 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PASVILDA Trademark

Serial Number: 79420232 • Registration: 7971755

PASVILDA is a trademark filed by SANDOZ AG on January 28, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SANDOZ AG (209 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

Trademark Details

Filing Date

January 28, 2025

Registration Date

October 7, 2025

Published for Opposition

August 19, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 6, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 7, 2025 R.PR
PUBLISHED FOR OPPOSITION
Aug 19, 2025 PUBO
NOTICE OF PUBLICATION
Aug 13, 2025 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 13, 2025 CNSA
ASSIGNED TO EXAMINER
Jul 8, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 30, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 30, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 28, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 27, 2025 REPR